Randomized Controlled Multi-center Short Course Treatment for Rifampicin Resistant Tuberculosis
Condition:   Tuberculosis Intervention:   Drug: Total oral short-term therapy that includes linezolid, bedaquiline and/or cycloserine. Sponsor:   Beijing Chest Hospital Recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - September 11, 2020 Category: Research Source Type: clinical trials

Continuous Infusion of Linezolid Versus Intermittent Dosing in the Treatment of Community-Acquired and Nosocomial Pneumonia
Condition:   Pneumonia Interventions:   Drug: Continuous infusion Linezolid;   Drug: intermittent dosing linezolid Sponsors:   October 6 University;   Beni-Suef University;   Critical Care Department,Cairo University Hospitals Active, not recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - August 28, 2020 Category: Research Source Type: clinical trials